# Verge Medical acquires RoVo System from 2MG Medical

Verge Medical acquired the RoVo System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical to enhance its peripheral embolic protection portfolio.

- Type: Acquisition
- Announced: 2025-06-30
- Where: Campbell, California, United States
- Status: completed
- Products: RoVo System, Temporary Occlusion Embolectomy technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Verge Medical](https://endata.com/companies/85678.md) (acquirer)
- [2MG Medical](https://endata.com/companies/85679.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/verge-medical-acquires-rovo-system-to-advance-peripheral-embolic-protection-302493956.html), 2025-06-30: "The acquisition enhances Verge's expanding portfolio of targeted, setting-specific solutions for coronary and peripheral vascular interventions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.